72.19.Z - Scientific research and development activities
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
75.00.Z - Veterinary activities
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | ||||
Gross profit (loss) | -0,6 | -1,3 | -0,2 | 84,8 |
EBITDA | -0,6 | -1,1 | -0,2 | 85,7 |
Short time liabilities | 0,1 | 0,1 | 0,1 | -6 |
Equity capital | 1,6 | 1,5 | 2,6 | 70,8 |
Operating profit (EBIT) | -0,6 | -1,2 | -0,2 | 85,1 |
Assets | 1,7 | 1,6 | 2,8 | 71,1 |
Net profit (loss) | -0,6 | -1,3 | -0,2 | 84,8 |
Cash | 1,6 | 1,1 | 0,2 | -80,7 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,1 | 77 |
Net income from sale | 0,4 | 0 | 0,2 | -∞ |
Working assets | 1,7 | 1,2 | 0,3 | -74 |
Depreciation | 0 | 0 | 0 | 216,8 |
% | % | % | p.p. | |
Profitability of capital | -35,4 | -83,6 | -7,4 | 76,2 |
Equity capital to total assets | 92,7 | 95,2 | 95,1 | -0,1 |
Gross profit margin | -158,2 | -87,7 | 70,5 | |
EBITDA Margin | -181,3 | -73,7 | 107,6 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 127 | 2 147 483 648 | 119 | -2 147 483 529 |
Current financial liquidity indicator | 13.714766502380371 | 16.122880935668945 | 2.3670854568481445 | -13,7 |
Net dept to EBITDA | 2.56189227104187 | 0.9165823459625244 | 1.2370569705963135 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane